Expression of Vascular Endothelial Growth Factor and E-Cadherin in Human Ovarian Cancer: Association with Ascites Fluid Accumulation and Peritoneal Dissemination in Mouse Ascites Model-Reference-Cited by-同舟云学术

Expression of Vascular Endothelial Growth Factor and E-Cadherin in Human Ovarian Cancer: Association with Ascites Fluid Accumulation and Peritoneal Dissemination in Mouse Ascites Model

Published:2002-06 Issue:6 Volume:93 Page:644-651
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Akutagawa Noriyuki,Nishikawa Akira,Iwasaki Masahiro,Fujimoto Takashi,Teramoto Mizue,Kitajima Yoshimitsu,Endo Toshiaki,Shibuya Masabumi,Kudo Ryuichi

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2002.tb01302.x/fullpdf

Reference46 articles.

1. Cancer Statistics in Japan databases http://www.ncc.go.jp/jp/statistics/2001/tables

2. What is the evidence that tumors are angiogenesis dependent;Folkman;J. Natl. Cancer Inst.,1990

3. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation;Liotta;Cell,1991

4. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma;Weidner;N. Engl. J. Med.,1991

5. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis;Dvorak;Am. J. Pathol.,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pro-inflammatory macrophage polarization enhances the anti-cancer efficacy of self-assembled galactomannan nanoparticles entrapped with hydrazinocurcumin;Drug Delivery and Translational Research;2019-08-22

2. Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment;Expert Review of Anticancer Therapy;2017-12-21

3. Preliminary study of the treatment effect of apatinib mesylate upon malignant ascites and its safety;Translational Cancer Research;2017-10

4. Effect of AURKA Gene Expression Knockdown on Angiogenesis and Tumorigenesis of Human Ovarian Cancer Cell Lines;Targeted Oncology;2016-06-02

5. Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study;Gynecologic Oncology;2015-10